The primary interests focus on the pathogenesis and treatment of chronic neurodegenerative diseases, many of which involve alterations in neurotransmitter receptor systems subserving normal CNS function as a result of derangements in peripheral organ function. For example, hepatic encephalopathy (HE) is a neuropsychiatric syndrome accompanying acute or chronic liver failure. It is characterized by personality changes, sleep inversion, generalized cognitive slowing, incoordination, and ataxia leading to coma. We are investigating the role that endogenous benzodiazepine receptor ligands, neurosteroids, and ammonia play in the pathogenesis of this syndrome and developing pharmacological interventions to deal with these changes. Present projects include: isolation and identification of the structures of benzodiazepine receptor agonists found in elevated levels in the brains of experimental models of acute liver failure; determination of the sources of these compounds and their regulation; investigation of the modulation of GABA-gated Cl- currents by pathophysiologically relevant concentrations of ammonia in cultured neuronal cell lines; determination of the efficacy of neurosteroid receptor antagonists and 5a-reductase inhibitors in reversing the physiological and behavioral manifestations of HE; determining the role of glutamatergic neurotransmission in the manifestations of HE. Another chronic neurodegenerative disorder under investigation is AIDS dementia complex. We are presently characterizing many of the basic immunological and neurological pathologies of two murine models of retrovirus-induced cognitive deficits. These models are being used to investigate the role of excitotoxins, cytokines and autoimmune factors in the pathogenesis of the behavioral and neurochemical abnormalities associated with retroviral infections in these mice, and treating them with with cytokine synthesis inhibitors, anti-inflammitories, or glutamate receptor antagonists, and then noting their efficacy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK032102-01
Application #
6161954
Study Section
Special Emphasis Panel (LBC)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Gladwin, Mark T; Shelhamer, James H; Ognibene, Frederick P et al. (2002) Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br J Haematol 116:436-44
Hess, Sonja; van Beek, Jacco; Pannell, Lewis K (2002) Acid hydrolysis of silk fibroins and determination of the enrichment of isotopically labeled amino acids using precolumn derivatization and high-performance liquid chromatography-electrospray ionization-mass spectrometry. Anal Biochem 311:19-26
Rashid, M A; Gustafson, K R; Cartner, L K et al. (2001) Microspinosamide, a new HIV-inhibitory cyclic depsipeptide from the marine sponge Sidonops microspinosa. J Nat Prod 64:117-21
Bokesch, H R; Pannell, L K; Cochran, P K et al. (2001) A novel anti-HIV macrocyclic peptide from Palicourea condensata. J Nat Prod 64:249-50
Li, Y F; Hess, S; Pannell, L K et al. (2001) In vivo mechanism-based inactivation of S-adenosylmethionine decarboxylases from Escherichia coli, Salmonella typhimurium, and Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 98:10578-83
Orsini, M A; Pannell, L K; Erickson, K L (2001) Polychlorinated acetamides from the cyanobacterium Microcoleus lyngbyaceus. J Nat Prod 64:572-7
Manfredi, K P; Vallurupalli, V; Demidova, M et al. (2001) Isolation of an anti-HIV diprenylated bibenzyl from Glycyrrhiza lepidota. Phytochemistry 58:153-7
Gustafson, K R; Walton, L K; Sowder Jr, R C et al. (2000) New circulin macrocyclic polypeptides from Chassalia parvifolia. J Nat Prod 63:176-8
Rashid, M A; Gustafson, K R; Boswell, J L et al. (2000) Haligramides A and B, two new cytotoxic hexapeptides from the marine sponge Haliclona nigra. J Nat Prod 63:956-9
Driscoll, W J; Konig, S; Fales, H M et al. (2000) Peptidylglycine-alpha-hydroxylating monooxygenase generates two hydroxylated products from its mechanism-based suicide substrate, 4-phenyl-3-butenoic acid. Biochemistry 39:8007-16

Showing the most recent 10 out of 23 publications